HEXARAD GROUP LIMITEDActive

Company number 10249971Private limited companyIncorporated 2016

Key figures

£9,720,192+238.0%
Net assets 2023/24
+263.2%
Average annual growth 2019/20–2023/24
02.5 m5 m7.5 m10 m2019/202020/212021/222022/232023/24

Like most small UK companies, HEXARAD GROUP LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m15 m2019/202020/212021/222022/232023/24
Filed accounts2019/20–2023/24
2019/202020/212021/222022/232023/24
Cash at bank and in hand37,8671,865,783623,4931,001,3407,105,704
Total assets126,0052,324,5431,275,4904,557,86513,557,977
Total liabilities71,171559,128797,4951,681,9913,683,794
Net assets / total equity55,8301,942,8551,069,4872,875,8749,720,192
Average number of employees58184155

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: HEXARAD GROUP LIMITED

Company

HEXARAD GROUP LIMITED is a private limited company registered with Companies House under company number 10249971. It was incorporated on 24 Jun 2016. Its status is active. The registered office is in Harrow (HA1). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2023/24 (period ending 30 Jun 2024); the company files full accounts. Net assets were £9,720,192, up 238% on the previous year. Cash at bank and in hand was £7,105,704. Total assets were £13,557,977 and total liabilities £3,683,794. The company had an average of 55 employees. Figures are available for 5 financial years (2019/20–2023/24).

Control and charges

2 persons with significant control are registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 15 Feb 2027.